These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 14756674)

  • 1. Effective long-term control of cardiac events with beta-blockers in a family with a common LQT1 mutation.
    Wedekind H; Schwarz M; Hauenschild S; Djonlagic H; Haverkamp W; Breithardt G; Wülfing T; Pongs O; Isbrandt D; Schulze-Bahr E
    Clin Genet; 2004 Mar; 65(3):233-41. PubMed ID: 14756674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Mechanism of Autosomal Recessive Long QT-Syndrome 1 without Deafness.
    Oertli A; Rinné S; Moss R; Kääb S; Seemann G; Beckmann BM; Decher N
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498651
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification and characterisation of a novel KCNQ1 mutation in a family with Romano-Ward syndrome.
    Zehelein J; Thomas D; Khalil M; Wimmer AB; Koenen M; Licka M; Wu K; Kiehn J; Brockmeier K; Kreye VA; Karle CA; Katus HA; Ulmer HE; Schoels W
    Biochim Biophys Acta; 2004 Nov; 1690(3):185-92. PubMed ID: 15511625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KCNQ1 mutations in patients with a family history of lethal cardiac arrhythmias and sudden death.
    Chen S; Zhang L; Bryant RM; Vincent GM; Flippin M; Lee JC; Brown E; Zimmerman F; Rozich R; Szafranski P; Oberti C; Sterba R; Marangi D; Tchou PJ; Chung MK; Wang Q
    Clin Genet; 2003 Apr; 63(4):273-82. PubMed ID: 12702160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and molecular genetic risk determinants in adult long QT syndrome type 1 and 2 patients : Koponen et al. Follow-up of adult LQTS patients.
    Koponen M; Havulinna AS; Marjamaa A; Tuiskula AM; Salomaa V; Laitinen-Forsblom PJ; Piippo K; Toivonen L; Kontula K; Viitasalo M; Swan H
    BMC Med Genet; 2018 Apr; 19(1):56. PubMed ID: 29622001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation analysis in congenital Long QT Syndrome--a case with missense mutations in KCNQ1 and SCN5A.
    Paulussen A; Matthijs G; Gewillig M; Verhasselt P; Cohen N; Aerssens J
    Genet Test; 2003; 7(1):57-61. PubMed ID: 12820704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A novel KCNQ1 mutation in Chinese with congenital long QT syndrome].
    Liang L; Du ZD; Cai LL; Wu JX; Zheng T; Qi TX
    Zhonghua Er Ke Za Zhi; 2003 Oct; 41(10):724-7. PubMed ID: 14731347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follow-up of 316 molecularly defined pediatric long-QT syndrome patients: clinical course, treatments, and side effects.
    Koponen M; Marjamaa A; Hiippala A; Happonen JM; Havulinna AS; Salomaa V; Lahtinen AM; Hintsa T; Viitasalo M; Toivonen L; Kontula K; Swan H
    Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):815-23. PubMed ID: 26063740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel KCNQ1 and HERG missense mutations in Dutch long-QT families.
    Jongbloed RJ; Wilde AA; Geelen JL; Doevendans P; Schaap C; Van Langen I; van Tintelen JP; Cobben JM; Beaufort-Krol GC; Geraedts JP; Smeets HJ
    Hum Mutat; 1999; 13(4):301-10. PubMed ID: 10220144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dominant-negative I(Ks) suppression by KCNQ1-deltaF339 potassium channels linked to Romano-Ward syndrome.
    Thomas D; Wimmer AB; Karle CA; Licka M; Alter M; Khalil M; Ulmer HE; Kathöfer S; Kiehn J; Katus HA; Schoels W; Koenen M; Zehelein J
    Cardiovasc Res; 2005 Aug; 67(3):487-97. PubMed ID: 15950200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Additional gene variants reduce effectiveness of beta-blockers in the LQT1 form of long QT syndrome.
    Kobori A; Sarai N; Shimizu W; Nakamura Y; Murakami Y; Makiyama T; Ohno S; Takenaka K; Ninomiya T; Fujiwara Y; Matsuoka S; Takano M; Noma A; Kita T; Horie M
    J Cardiovasc Electrophysiol; 2004 Feb; 15(2):190-9. PubMed ID: 15028050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-blocker therapy failures in symptomatic probands with genotyped long-QT syndrome.
    Chatrath R; Bell CM; Ackerman MJ
    Pediatr Cardiol; 2004; 25(5):459-65. PubMed ID: 15534720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in conserved amino acids in the KCNQ1 channel and risk of cardiac events in type-1 long-QT syndrome.
    Jons C; Moss AJ; Lopes CM; McNitt S; Zareba W; Goldenberg I; Qi M; Wilde AA; Shimizu W; Kanters JK; Towbin JA; Ackerman MJ; Robinson JL
    J Cardiovasc Electrophysiol; 2009 Aug; 20(8):859-65. PubMed ID: 19490272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biophysical characterization of KCNQ1 P320 mutations linked to long QT syndrome 1.
    Thomas D; Khalil M; Alter M; Schweizer PA; Karle CA; Wimmer AB; Licka M; Katus HA; Koenen M; Ulmer HE; Zehelein J
    J Mol Cell Cardiol; 2010 Jan; 48(1):230-7. PubMed ID: 19540844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional Characterization of a Spectrum of Novel Romano-Ward Syndrome
    Rinné S; Oertli A; Nagel C; Tomsits P; Jenewein T; Kääb S; Kauferstein S; Loewe A; Beckmann BM; Decher N
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KCNQ1 and KCNH2 mutations associated with long QT syndrome in a Chinese population.
    Liu W; Yang J; Hu D; Kang C; Li C; Zhang S; Li P; Chen Z; Qin X; Ying K; Li Y; Li Y; Li Z; Cheng X; Li L; Qi Y; Chen S; Wang Q
    Hum Mutat; 2002 Dec; 20(6):475-6. PubMed ID: 12442276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulating effects of age and gender on the clinical course of long QT syndrome by genotype.
    Zareba W; Moss AJ; Locati EH; Lehmann MH; Peterson DR; Hall WJ; Schwartz PJ; Vincent GM; Priori SG; Benhorin J; Towbin JA; Robinson JL; Andrews ML; Napolitano C; Timothy K; Zhang L; Medina A;
    J Am Coll Cardiol; 2003 Jul; 42(1):103-9. PubMed ID: 12849668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene.
    Moss AJ; Shimizu W; Wilde AA; Towbin JA; Zareba W; Robinson JL; Qi M; Vincent GM; Ackerman MJ; Kaufman ES; Hofman N; Seth R; Kamakura S; Miyamoto Y; Goldenberg I; Andrews ML; McNitt S
    Circulation; 2007 May; 115(19):2481-9. PubMed ID: 17470695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low incidence of sudden cardiac death in a Swedish Y111C type 1 long-QT syndrome population.
    Winbo A; Diamant UB; Stattin EL; Jensen SM; Rydberg A
    Circ Cardiovasc Genet; 2009 Dec; 2(6):558-64. PubMed ID: 20031635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A founder mutation of the potassium channel KCNQ1 in long QT syndrome: implications for estimation of disease prevalence and molecular diagnostics.
    Piippo K; Swan H; Pasternack M; Chapman H; Paavonen K; Viitasalo M; Toivonen L; Kontula K
    J Am Coll Cardiol; 2001 Feb; 37(2):562-8. PubMed ID: 11216980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.